WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018030878) VACCINE COMPOSITION FOR PREVENTING PORCINE MYCOPLASMA INFECTION, COMPRISING RECOMBINANT PROTEIN
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/030878    International Application No.:    PCT/KR2017/008851
Publication Date: 15.02.2018 International Filing Date: 14.08.2017
IPC:
C12N 15/74 (2006.01), C07K 14/30 (2006.01), A61K 39/02 (2006.01), A61K 39/00 (2006.01)
Applicants: INNOVAC [KR/KR]; 2F, 37, Useok-ro Chuncheon-si Gangwon-do 24326 (KR)
Inventors: HAHN, Tae Wook; (KR).
BARATE, Kashinath Abhijit; (KR).
KIM, Ki Ju; (KR).
SHIN, Woo Sung; (KR)
Agent: KIM, Soon Woong; (KR)
Priority Data:
10-2016-0103259 12.08.2016 KR
Title (EN) VACCINE COMPOSITION FOR PREVENTING PORCINE MYCOPLASMA INFECTION, COMPRISING RECOMBINANT PROTEIN
(FR) COMPOSITION VACCINALE DESTINÉE À PRÉVENIR L'INFECTION PAR LES MYCOPLASMES PORCINS COMPRENANT UNE PROTÉINE RECOMBINÉE
(KO) 재조합 단백질을 포함하는 돼지 마이코플라즈마 감염 예방용 백신 조성물
Abstract: front page image
(EN)The present invention relates to a recombinant protein for vaccine preparation for preparing a vaccine for the prevention of porcine mycoplasma infection, and a vaccine composition for preventing porcine mycoplasma hyopneumoniae and mycoplasma hyorhinis infection comprising a recombinant protein. When the recombinant proteins for vaccine preparation of the present invention are added to a vaccine composition for the prevention of porcine mycoplasma infection, the recombinant proteins for vaccine preparation of the present invention can exert an excellent defense effect over conventional commercial vaccines by increasing an immune response against porcine mycoplasma hyopneumoniae and porcine mycoplasma hyorhinis strains and an immune response against a P97 protein. Therefore, the recombinant protein for vaccine preparation of the present invention and the vaccine composition using the same can effectively prevent diseases caused by infection of mycoplasma hyopneumoniae and mycoplasma hyorhinis, in particular, porcine mycoplasma pneumonia and porcine mycoplasma arthritis.
(FR)La présente invention concerne une protéine recombinée utilisée pour une préparation vaccinale servant à préparer un vaccin destiné à lutter contre l'infection par les mycoplasmes porcins, et une composition vaccinale comprenant une protéine recombinée destinée à prévenir l'infection à Mycoplasma hyopneumoniae et à Mycoplasma hyorhinis chez le porc. Lorsque les protéines recombinées utilisées pour la préparation vaccinale selon la présente invention sont ajoutées à une composition vaccinale pour prévenir l'infection par les mycoplasmes chez le porc, lesdites protéines recombinées sont capables de conférer à l'animal une excellente défense par rapport aux vaccins conventionnels commercialisés en augmentant la réponse immunitaire du porc vis-à-vis de Mycoplasma hyopneumoniae et de Mycoplasma hyorhinis et la réponse immunitaire du porc vis-à-vis de la protéine P97. La protéine recombinée utilisée pour une préparation vaccinale selon la présente invention, et la composition vaccinale l'utilisant sont donc capables de prévenir efficacement les maladies provoquées par l'infection à Mycoplasma hyopneumoniae et à Mycoplasma hyorhinis, en particulier la pneumonie et l'arthrite du porc provoquées par des mycoplasmes.
(KO)본 발병은 돼지 마이코플라즈마 감염 예방용 백신을 제조하기 위한 백신 제조용 재조합 단백질 및 재조합 단백질을 포함하는 돼지 마이코플라즈마 하이오뉴모니애 및 마이코플라즈마 하이오라이니스 감염 예방용 백신 조성물에 관한 것이다. 본 발명의 백신 제조용 재조합 단백질들은 돼지 마이코플라즈마 감염 예방용 백신 조성물에 첨가되는 경우, 돼지 마이코플라즈마 하이오뉴모니애와 돼지 마이코플라즈마 하이오라이니스 균주에 대한 면역반응과 P97 단백질에 대한 면역반응을 증가시킴으로써 기존 상용 백신보다 우수한 방어 효과를 나타낼 수 있다. 따라서 본 발명의 백신 제조용 재조합 단백질 및 이를 이용한 백신 조성물은 마이코플라즈마 하이오뉴모니애와 마이코플라즈마 하이오라이니스의 감염에 의해 발생하는 질병, 특히 돼지 마이코플라즈마성 폐렴과 돼지 마이코플라즈마성 관절염을 효과적으로 예방할 수 있다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)